tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (TEVA)
NYSE:TEVA

Teva Pharmaceutical (TEVA) Revenue

Compare
7,261 Followers

Teva Pharmaceutical Revenue

Teva Pharmaceutical had a revenue of 3.89B in the quarter ending Mar 31, 2025, with -7.99%. This bring the company's revenue in the last twelve months to 16.61B, Decreased 0.36%. In the fiscal year ending Dec 31, 2024, Teva Pharmaceutical had annual revenue of 16.54B with 4.40% growth.
Revenue (ttm)
16.61B
Revenue Growth
3.38%
P/S Ratio
1.20
Revenue/Employee
$447,135
Employees
37,000
Market Cap
$19.87B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
16.54B698.00M+4.40%
Dec 31, 2023
15.85B921.00M+6.17%
Dec 31, 2022
14.93B-953.00M-6.00%
Dec 31, 2021
15.88B-780.00M-4.68%
Dec 31, 2020
16.66B-229.00M-1.36%
Dec 31, 2019
16.89B-1.97B-10.43%
Dec 31, 2018
18.85B-3.53B-15.77%
Dec 31, 2017
22.39B482.00M+2.20%
Dec 31, 2016
21.90B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis